NEW YORK (GenomeWeb News) – German regulators have cleared Hologic's $3.7 billion purchase of Gen-Probe, the two companies said today.

The deal, under which Hologic will pay $82.75 for each share of Gen-Probe stock, cleared US antitrust review last month and with clearance from Germany's Federal Cartel Office, required antitrust clearances have been received, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.